Obesity Medicine | Montefiore Einstein

Dr. Machineni obtained his medical degree from the All India Institute of Medical Sciences in New Delhi, followed by a residency in internal medicine at the State University of New York at  Buffalo. He served as chief resident and primary care teaching physician at Buffalo General Hospital. He subsequently completed a clinical and research fellowship in obesity medicine and metabolism at Massachusetts General Hospital/ Harvard Medical School and stayed on as an instructor. Dr. Machineni studied energy balance and body fat regulation in animal models allowing the interpretation of clinical research findings and phenotypes in the context of physiology. 
 
Dr. Machineni moved to the University of North Carolina at Chapel Hill (UNC) to start a clinical obesity program for treatment, education, and pharmaceutical clinical obesity trials. During his term at UNC, he helped create an obesity primary care network in central North Carolina. He was recruited to Montefiore Medical Center to develop a new medical obesity program.
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">The Fleischer Institute Medical Weight Center at Montefiore Einstein, founded by Dr. Machineni, is designed to support clinical, educational, and research endeavors in the field of obesity medicine. The program leverages individual variations in response to treatments and uses multiple modalities for weight reduction to treat the comorbidities of obesity and improve quality of life. Special programs are available for individuals who need to lose weight to quality for medical and surgical procedures. The Medical Weight Center works closely with the Montefiore bariatric surgery program to offer a broad spectrum of treatment modalities.
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Dr. Machineni has clinical expertise in the multidisciplinary management of obesity, anti-obesity medications, and post-bariatric medical complications, including nutritional deficiencies, hypoglycemia, weight regain, malabsorption, and diarrhea. He is among a handful of physicians in the New York area with Castle Connolly Top Doctors designation in obesity medicine.
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">

Research Areas

Improving treatment access, identifying predictors for the variability of response to obesity treatments, and clinical trials of innovative anti-obesity treatments.

Research Profile

https://einsteinmed.edu/faculty/17510/Sriram-Machineni

Clinical Profile

https://montefioreeinstein.org/profiles/1750350666/sriram-machineni

CHAM Provider

Off

Professional Title

M.B.,B.S.

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/ee37ba2e-b4de-4691-8cf7-2f147840f…

Selected Publications

1: Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H,Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM; SURMOUNT-2 investigators.Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023 Jun 26:S0140-6736(23)01200-X. doi:10.1016/S0140-6736(23)01200-X. Epub ahead of print. PMID: 37385275.
2: Pagidipati NJ, Mulder H, Chiswell K, Lampron Z, Jones WS, Machineni S,Waitman LR, Mongraw-Chaffin M, Waterman F, Kumar N, Ramasamy A, Smolarz G,Peterson ED, O'Brien E. Evaluation of weight change and cardiometabolic risk factors in a real-world population of US adults with overweight or obesity. PrevMed. 2023 May;170:107496. doi:10.1016/j.ypmed.2023.107496. Epub 2023 Mar 29.PMID: 36997096.
3: Ro SJ, Lackey AR, Aymes SE, McCauley JL, Davis TC, Wang R, Stanley W, Ratner SP, Machineni S, Fiscus LC. Impact of a Community-Based Weight Management Program in a North Carolina Health Care System. Fam Med. 2023 Mar;55(3):189-194.doi: 10.22454/FamMed.2023.603918. Epub 2023 Jan 31. PMID: 36888674.
4: Aronne LJ, Bramblette S, Ingelfinger JR, Jastreboff AM, Machineni S, Massie N, Rosen CJ. When Weight Impacts Health. N Engl J Med. 2023 Jan 12;388(2):e2. doi: 10.1056/NEJMp2215794. PMID: 36630621.
5: Aronne LJ, Bramblette S, Huett-Garcia A, Ingelfinger JR, Jastreboff AM, Machineni S, Massie N, Rosen CJ. Weight and Health - Pathophysiology and Therapies. N Engl J Med. 2022 Dec 15;387(24):e62. doi: 10.1056/NEJMp2214423. PMID: 36516089.
6: le Roux CW, Zhang S, Aronne LJ, Kushner RF, Chao AM, Machineni S, Dunn J, Chigutsa FB, Ahmad NN, Bunck MC. Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program. Obesity (Silver Spring). 2023 Jan;31(1):96-110. doi: 10.1002/oby.23612. Epub 2022 Dec 7. PMID: 36478180; PMCID: PMC10107501.
7: Bionic Pancreas Research Group; Russell SJ, Beck RW, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Calhoun P, Wadwa RP, Buckingham B, Zhou K,Daniels M, Raskin P, White PC, Lynch J, Pettus J, Hirsch IB, Goland R, Buse JB,Kruger D, Mauras N, Muir A, McGill JB, Cogen F, Weissberg-Benchell J, Sherwood JS, Castellanos LE, Hillard MA, Tuffaha M, Putman MS, Sands MY, Forlenza G, Slover R, Messer LH, Cobry E, Shah VN, Polsky S, Lal R, Ekhlaspour L, Hughes MS, Basina M, Hatipoglu B, Olansky L, Bhangoo A, Forghani N, Kashmiri H, Sutton F, Choudhary A, Penn J, Jafri R, Rayas M, Escaname E, Kerr C, Favela-Prezas R, Boeder S, Trikudanathan S, Williams KM, Leibel N, Kirkman MS, Bergamo K, Klein KR, Dostou JM, Machineni S, Young LA, Diner JC, Bhan A, Jones JK, Benson M, Bird K, Englert K, Permuy J, Cossen K, Felner E, Salam M, Silverstein JM, Adamson S, Cedeno A, Meighan S, Dauber A. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. 2022 Sep 29;387(13):1161-1172. doi: 10.1056/NEJMoa2205225. PMID: 36170500; PMCID: PMC10028490.
8: Perreault L, Davies M, Frias JP, Laursen PN, Lingvay I, Machineni S, Varbo A,Wilding JPH, Wallenstein SOR, le Roux CW. Changes in Glucose Metabolism andGlycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg AmongParticipants With Prediabetes in the STEP Program. Diabetes Care. 2022 Oct1;45(10):2396-2405. doi: 10.2337/dc21-1785. PMID: 35724304; PMCID: PMC9862484.
9: Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A,Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. TirzepatideOnce Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024.
10: Klein KR, Freeman JLR, Dunn I, Dvergsten C, Kirkman MS, Buse JB, Valcarce C;SimpliciT1 research group. The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes. Diabetes Care. 2021 Apr;44(4):960-968. doi:10.2337/dc20-2684. Epub 2021 Feb 23. PMID:33622669; PMCID: PMC7985421.
11: Melanie Davies, Louise Færch, Ole K Jeppesen, Arash Pakseresht, Sue D Pedersen, Leigh Perreault, Julio Rosenstock, Iichiro Shimomura, Adie Viljoen, Thomas A Wadden, Ildiko Lingvay; STEP 2 Study Group.  Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021 Mar 13;397(10278):971-984. PMID: 33667417.
12: Rosman L, Armbruster T, Kyazimzade S, Tugaoen Z, Mazzella AJ, Deyo Z, Walker J, Machineni S, Gehi A. Effect of a virtual self-management intervention for atrial fibrillation during the outbreak of COVID-19. Pacing Clin Electrophysiol. 2021 Mar;44(3):451-461. doi: 10.1111/pace.14188. Epub 2021 Feb 17. PMID: 33565642; PMCID: PMC8014277.
13: Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, O'Neil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT; STEP 3 Investigators. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021 Feb 24. PMID: 33625476; PMCID: PMC7905697.
14: Jensen SM, Thompson RE, Machineni S, Overby DW, Farrell TM. Refractory Hypocalcemia Following Stomach Intestinal Pylorus-Sparing Bariatric Surgery and Thyroidectomy: Successful Management With Creation of a Proximal Roux-en-Y Gastric Bypass. Am Surg. 2021 Apr;87(4):576-580. doi: 10.1177/0003134820952427. Epub 2020 Oct 30. PMID: 33125276.
 
15: Kushner RF, Batsis JA, Butsch WS, Davis N, Golden A, Halperin F, Kidambi S, Machineni S, Novick M, Port A, Rubino DM, Saunders KH, Shapiro Manning L, Soleymani T, Kahan S. Weight History in Clinical Practice: The State of the Science and Future Directions. Obesity (Silver Spring). 2020 Jan;28(1):9-17. doi: 10.1002/oby.22642. PMID: 31858735.
16: Kushner RF, Butsch WS, Kahan S, Machineni S, Cook S, Aronne LJ. Obesity Coverage on Medical Licensing Examinations in the United States. What Is Being Tested? Teach Learn Med. 2017 Apr-Jun;29(2):123-128. doi:10.1080/10401334.2016.1250641. Epub 2016 Dec 29. PMID: 28033472.
17: Carmody JS, Ahmad NN, Machineni S, Lajoie S, Kaplan LM. Weight Loss After RYGB Is Independent of and Complementary to Serotonin 2C Receptor Signaling in Male Mice. Endocrinology. 2015 Sep;156(9):3183-91. doi: 10.1210/en.2015-1226. Epub 2015 Jun 11. PMID: 26066076; PMCID: PMC4541621.
18: Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013 Mar 27;5(178):178ra41. doi:10.1126/scitranslmed.3005687. PMID: 23536013; PMCID: PMC3652229.
19: Bose M, Teixeira J, Olivan B, Bawa B, Arias S, Machineni S, Pi-Sunyer FX, Scherer PE, Laferrère B. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes. 2010 Mar;2(1):47-55. doi: 10.1111/j.1753-0407.2009.00064.x. PMID: 20676394; PMCID: PMC2910618.
20: Bose M, Machineni S, Oliván B, Teixeira J, McGinty JJ, Bawa B, Koshy N, Colarusso A, Laferrère B. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring). 2010 Jun;18(6):1085-91. doi: 10.1038/oby.2009.473. Epub 2010 Jan 7.PMID: 20057364; PMCID: PMC2877144.

EMR ID

179058

Is Open Scheduling

Off

Shwetha V. Iyer

Read more about Shwetha V. Iyer

Shwetha V. Iyer

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/3842edc0-092e-11ee-9513-abe9ef574488.jpg

Provider

Faculty

First Name

Shwetha

Last Name

Iyer

NPI

1326332503

Faculty ID

13015

CMO Specialties

Clinical Terms

Annual Wellness Visits

Annual Physical

Sore Throat

Snoring

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

einstein-dept-family-social-med

Gender

Female

Provider Type

Primary Care

siyer@montefiore.org

Phone

718-579-2823

Titles

Type

Academic

Department

Department of Medicine

Department Link

Rank

Associate Professor

Division

General Internal Medicine

Type

Academic

Department

Department of Family and Social Medicine

Department Link

Rank

Associate Professor

Type

Administrative

Title

Program Director

Tags

einstein-primary-care-social-internal-medicine-program-leadership

Locations

Is Primary

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.91543 40.82478)

Address Line 1

305 East 161st Street

City

Bronx

State

Zip

10451-3535

Location Title

Montefiore Medical Group-Comprehensive Health Care Center (CHCC)

Is Primary

Off

Type

Academic

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.8799923 40.8838428)

Room

324

Address Line 1

Montefiore Medical Center

Address Line 3

3544 Jerome Avenue

City

Bronx

State

Zip

10467

Location Title

Montefiore Medical Center

Education and Trainings

Education Type Label

Medical Education

Education Institution

Temple University Lewis Katz School of Medicine

Education Type Label

Residency

Education Institution

Montefiore Medical Center

Professional Interests

<ul type="disc">
<li class="MsoNormal" style="color: #373a3c; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; background: #FEFEFE;">Dr. Shwetha Iyer is Program Director of the Primary Care/Social Internal Medicine Program at Montefiore Medical Center/Albert Einstein College of Medicine. She received her medical degree from Temple University and completed her residency in the Primary Care/Social Internal Medicine Program Track at Montefiore. She developed and completed training as a global health faculty fellow in the Global Health and Clinical Skills Fellowship at Montefiore. Her area of interest includes medical education, specifically in curriculum development and coaching. She has adapted and teaches a weight management curriculum for residents, developed and co-directs the clinical reasoning curriculum, and has refined the advocacy and women’s health curriculum for the residency program. Her current curricular focus is the development of the Master Adaptive Learner model and structural competency in residency education.  Prior to her current position, she served as Associate Program Director for the Primary Care/Social Internal Medicine Program</li>
</ul>

Research Areas

Master Adaptive Learner
Structural Competency
Stigma in written language
Immigrant health education
Lifestyle Medicine

Research Profile

https://einsteinmed.edu/faculty/13015/Shwetha-Iyer

Clinical Profile

https://montefioreeinstein.org/profiles/1326332503/shwetha-v-iyer

CHAM Provider

Off

Professional Title

M.D.

Clinical Focus

Dr. Iyer's clinical interests include obesity medicine, lifestyle medicine, and coaching patients toward their health goals.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Iyer's research focus is on the development and evaluation of medical education, lifestyle interventions, and structural competency.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/782c5b1c-821e-4a06-8257-05aeac863…

Selected Publications

<ul style="margin-top: 0in;" type="disc">
<li class="paragraph" style="margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1; vertical-align: baseline;">Iyer S, Jay M, Southern W, Schlair S. Assessing and Counseling the Obese Patient: Improving Resident Obesity Counseling Competence. Obesity Research and Clinical Practice. 2018 Mar - Apr;12(2):242-245. doi: 10.1016/j.orcp.2018.02.007. Epub 2018 Mar 16. </li>
<li class="paragraph" style="margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1; background: white; vertical-align: baseline;">Wang L, Iyer S, Browder C, Cunningham C. Internal Medicine Residents’ Attitudes Regarding Opioid Overdose Prevention and Naloxone Prescribing. Journal of Addiction Medicine. Subst Abus. 2018;39(3):371-376.doi: 10.1080/08897077.2018.1439800. Epub 2018 May 15. </li>
<li class="paragraph" style="margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1; background: white; vertical-align: baseline;">Iyer S, Goss E, Browder C, Paccione G, Arnsten J. Development and evaluation of a clinical reasoning curriculum as part of an Internal Medicine Residency Program. Diagnosis. 2019 Jun 26;6(2):115-119. doi: 10.1515/dx-2018-0093.</li>
<li class="paragraph" style="margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1; vertical-align: baseline;">Goss, E., Iyer, S., Arnsten, J. et al. Liberation Medicine: a Community Partnership and Health Advocacy Curriculum for Internal Medicine Residents. J GEN INTERN MED 35, 3102–3104 (2020). <a href="https://doi.org/10.1007/s11606-019-05518-1" target="_blank" rel="noopener">https://doi.org/10.1007/s11606-019-05518-1</a> </li>
<li class="paragraph" style="margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1; vertical-align: baseline;">Holaday L, Gover M, Iyer S, DeLuca J, Stella J, Gold M, Goss E. Effectiveness of training primary care internal medicine residents in etonogestrel implants and impact on their future practice: A cross sectional study. Contraception. 2022 July 30. Vol 115, p31-35. <a href="https://doi.org/10.1016/j.contraception.2022.07.013" target="_blank" rel="noopener">https://doi.org/10.1016/j.contraception.2022.07.013</a></…;
</ul>
Hamso, M and Iyer, S. Chapter 25: Federally Qualified Health Centers. In Leading a Medical Practice. Springer Publications. February 2018. Editors: Lu, L.B., Barrette, E.-P., Noronha, C., Sobel, H.G., Tobin, D.G. (2022: 2nd edition in press)

EMR ID

5070

Biography

Shwetha Iyer, MD, is Program Director, Primary Care/Social Internal Medicine Program and Associate Professor, Medicine and Family and Social Medicine at Montefiore Einstein. Her clinical interests include obesity medicine, lifestyle medicine and coaching patients toward their health goals.After obtaining her Bachelor of Science in public health from Rutgers University in 2004, Dr. Iyer earned her Doctor of Medicine at Temple University in 2008. She then came to Einstein to complete her internship and residency in the Primary Care/Social Internal Medicine Program in 2011 and a faculty fellowship in global health and clinical skills in 2014.Dr. Iyer’s research is focused on the development and evaluation of medical education, lifestyle interventions and structural competency. Her work has been published in numerous original communications in peer-reviewed journals as well as books, chapters and review articles. Dr. Iyer has given national and international invited presentations and has been Principal Investigator and Co-Principal Investigator on several funded research projects.Dr. Iyer is board certified in Internal Medicine by the National Board of Medical Examiners and is a Diplomat of the American Board of Obesity Medicine and the American Board of Lifestyle Medicine. She is a member of the Society of General Internal Medicine and the Association of Program Directors in Internal Medicine. In 2022, Dr. Iyer won the Leo M. Davidoff Society Award for Excellence in the Education of Medical Students.

Is Open Scheduling

Muhammad Jahanzaib Anwar

Read more about Muhammad Jahanzaib Anwar

Muhammad Jahanzaib Anwar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/c39f39e0-5361-11ef-8b06-8384e0847729.jpg

Provider

Faculty

First Name

Muhammad Jahanzaib

Last Name

Anwar

NPI

1700362811

Faculty ID

17841

CMO Specialties

Clinical Terms

Annual Wellness Visits

Annual Physical

Sore Throat

Snoring

Employment Status

Full Time

Patient Type

Adult

Department

einstein-dept-medicine

Gender

Male

Provider Type

Primary Care

muhammadjahanzaib.anwar@einsteinmed.edu

Phone

866-633-8255

Titles

Type

Academic

Type

Academic

Department

Department of Medicine

Department Link

Rank

Assistant Professor

Division

General Internal Medicine

Type

Administrative

Title

Medical Director of Student Health

Locations

Is Primary

Type

Clinical

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.84907 40.85098)

Address Line 1

1180 Morris Park Avenue

City

Bronx

State

Zip

10461-1925

Location Title

Montefiore Wellness Center

Is Primary

Off

Type

Academic

Location (Address, State, City, Zip)

Not used, will be deleted

Coordinates

POINT (-73.8489865 40.8506664)

Address Line 1

Montefiore Medical Center

Address Line 3

1180 Morris Park Avenue

City

Bronx

State

Zip

10461

Location Title

Montefiore Medical Center

Education and Trainings

Education Type Label

Medical Education

Education Institution

Quaid-i-Azam Medical College

Education Type Label

Residency

Education Institution

Montefiore Medical Center

Professional Interests

Dr. Anwar focuses on providing patient-centered primary care services. His areas of interest include medical student and resident burnout, weight management services, and physician leadership.

Research Profile

https://einsteinmed.edu/faculty/17841/Muhammad Jahanzaib-Anwar

Clinical Profile

https://montefioreeinstein.org/profiles/1700362811/muhammad-jahanzaib-anwar

CHAM Provider

Off

Professional Title

M.B.,B.S.

Clinical Focus

Adult Medicine

Elsevier Profile

https://einstein.pure.elsevier.com/en/persons/c199239e-3bec-4d0c-8e7f-31478ba72…

Selected Publications

1: Rossi M, Jahanzaib Anwar M, Usman A, Keshavarzian A, Bishehsari F. Colorectal Cancer and Alcohol Consumption-Populations to Molecules. Cancers (Basel). 2018 Jan 30;10(2):38. doi: 10.3390/cancers10020038. PMID: 29385712; PMCID: PMC5836070.
2: Choudhry SA, Anwar MJ, Afzal M, Shah A. Foodborne Botulism, I Only Had Nacho Cheese: A Case Report. Cureus. 2017 Sep 8;9(9):e1666. doi: 10.7759/cureus.1666. PMID: 29152423; PMCID: PMC5677338.
3: Ali A, Ali NS, Nasir U, Aadil M, Waqas N, Zil-E-Ali A, Anwar MJ, Anjum I. Comparison of Knowledge and Attitudes of Medical and Dental Students towards HIV/AIDS in Pakistan. Cureus. 2018 Apr 4;10(4):e2426. doi: 10.7759/cureus.2426. PMID: 30079278; PMCID: PMC6067834.
4: Aadil M, Faraz A, Anwar MJ, Shoaib M, Nasir U, Akhlaq A. A Case of Munchausen Syndrome Presenting with Hematemesis: A Case Report. Cureus. 2017 Jun 13;9(6):e1348. doi: 10.7759/cureus.1348. PMID: 28979830; PMCID: PMC5626170.
5: Anwar MJ, Choudhry SA, Aadil M, Asif A, Ameer A. Idiopathic Acquired Dacryocystocele Presenting Only with Epiphora: A Very Rare Case Report. Cureus. 2017 Sep 4;9(9):e1653. doi: 10.7759/cureus.1653. PMID: 29142801; PMCID: PMC5669535.
6: Aadil M, Munir A, Anwar MJ, Arshad H, Anjum I, Faraz A. Psychiatric Symptoms as the First Clinical Presentation of Multiple Sclerosis: A Case Report. Cureus. 2017 Jul 15;9(7):e1474. doi: 10.7759/cureus.1474. PMID: 28944113; PMCID: PMC5602275.
7: Aadil M, Munir A, Arshad H, Tariq F, Anwar MJ, Amjad N, Akhlaq A. Consanguinity Associated with Increased Prevalence and Severity of Bipolar Disorder in Pakistan: A Case Report Highlighting the Genetic Link. Cureus. 2017 Jul 13;9(7):e1467. doi: 10.7759/cureus.1467. PMID: 28936379; PMCID: PMC5597064.

EMR ID

13872

Is Open Scheduling

Off

Subscribe to Obesity Medicine